Veterinary Medicine Information website

COCCIRIL 2.5 MG/ML ORAL SUSPENSION FOR CATTLE AND SHEEP

Authorised
  • Diclazuril

Product identification

Medicine name:
COCCIRIL 2.5 MG/ML ORAL SUSPENSION FOR CATTLE AND SHEEP
Active substance:
  • Diclazuril
Target species:
  • Cattle (calf)
  • Sheep (lamb)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Diclazuril
    2.50
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Cattle (calf)
      • Meat and offal
        0
        day
    • Sheep (lamb)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP51BC03
Authorisation status:
  • Valid
Authorised in:
  • Finland
Package description:
  • White, high-density polyethylene back-pack bottle of 1 L closed with black screw closure made of polypropylene with a polyethylene-lined sealing disk (wadding) for induction sealing inside. One 1 L back-pack bottle per cardboard box together with a spigot cap and back-pack strap.
  • White, high-density polyethylene back-pack bottle of 5 L closed with black screw closure made of polypropylene with a polyethylene-lined sealing disk (wadding) for induction sealing inside. One 5 L back-pack bottle per cardboard box together with a spigot cap and back-pack strap.
  • White, high-density polyethylene hanging bottle of 250 mL closed with black screw closure made of polypropylene with a polyethylene-lined sealing disk (wadding) for induction sealing inside. One 250 mL bottle per cardboard box together with a spigot cap.
  • White, high-density polyethylene back-pack bottle of 2,5 L closed with black screw closure made of polypropylene with a polyethylene-lined sealing disk (wadding) for induction sealing inside. One 2.5 L back-pack bottle per cardboard box together with a spigot cap and back-pack strap.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biovet AD
Responsible authority:
  • Finnish Medicines Agency
Authorisation number:
  • 43403
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0479/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Generic of:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 23/03/2026

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 23/03/2026